ET
IMCR icon

Entropy Technologies’s Immunocore IMCR Stock Holding History

Entropy Technologies’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$404K Buy
12,720
+2,700
+27% +$79.9K 0.02% 722
2026
Q1 		$302K Buy
+10,020
New +$324K 0.01% 700

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Entropy Technologies's IMCR Position: Q2 2026 in Review

Entropy Technologies increased its Immunocore (IMCR) stake by 27% in Q2 2026, buying an estimated $79.9K and bringing the position to 12,720 shares worth $404K. The position accounts for 0.02% of the portfolio, ranked #722.

Entropy Technologies first reported a position in IMCR in Q1 2026 and has held it in 2 quarters since. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Entropy Technologies held 12,720 shares of Immunocore worth $404K as of Q2 2026.
  • Entropy Technologies bought 2,700 Immunocore shares in Q2 2026, an estimated $79.9K.
  • Immunocore made up 0.02% of Entropy Technologies's portfolio in Q2 2026, its #722 holding.
  • Entropy Technologies first reported a position in Immunocore in Q1 2026 and has held it in 2 quarters since.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.